GSK, Association of the British Pharmaceutical Industry (ABPI) and UK Government's involvement in SARS-CoV-2 jabs
In those prophetic words in the M&M advert, "now it makes sense!"
GSK and Stevenage
In this previous post, we learnt about Autolus Therapeutics’ CAR-T Cell Manufacturing Facility, Stevenage, UK:
UK Town Centre gets an injection of gene therapy—hazardous chemicals and emissions galore
INSIDE PHARMA is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. Does Stevenage Town Centre know what’s coming it’s way? This is what’s coming down the line for Stevenage Town Centre:
There were a number of suspicious goings-on, such as Autolus’ partnership with Moderna, with little (nothing) in the Autolus product pipeline, and hazardous chemicals entering Stevenage town centre to be processed into materials for clinical trial supplies.
So, why Stevenage?
Well, in 1987, Glaxo decided to build a giant R&D Centre on a site in Stevenage under the name Glaxo Wellcome R&D.